港股早評:恆指再度下破2萬點 科技股普跌 新東方在線績後開漲近15%
格隆匯8月29日丨鮑威爾鷹派發言致上週五美股重挫,全球金融市場聞聲下跌。港股低開,恆指跌1.04%再度失守2萬點,國指跌1.07%,恆生科技指數跌1.24%。盤面上,中美簽署審計監管合作協議,回港中概股部分上漲,百度、貝殼、京東均上漲,網易、騰訊、小米、快手等科技股普跌,美團業績超預期,高開近4%;生物科技股下跌明顯,光伏股、手機概念股、內險股、海運股、有色金屬股齊挫。另一方面,紙業股、體育用品股、香港地產股個別走高。2022財年淨虧損同比收窄67.8%,新東方在線大漲近15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.